We are live on ! Find out more
FC

FIC Capital Portfolio holdings

AUM $262M
1-Year Est. Return 34.37%
This Fund
S&P 500
This Quarter Est. Return
+11.32%
1 Year Est. Return
+34.37%
3 Year Est. Return
+49.66%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$262M
AUM Growth
+$19.3M
Cap. Flow
-$4.64M
Cap. Flow %
-1.77%
Top 10 Hldgs %
38.33%
Holding
121
New
5
Increased
22
Reduced
60
Closed
2

Top Buys

Rank Stock Value
1
BSV icon
Vanguard Short-Term Bond ETF
BSV
+$1.39M
2
IPHI
INPHI CORPORATION
IPHI
+$867K
3
BKR icon
Baker Hughes
BKR
+$746K
4
AVGO icon
Broadcom
AVGO
+$283K
5
BA icon
Boeing
BA
+$209K

Top Sells

Rank Stock Value
1
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$1.68M
2
COL
Rockwell Collins
COL
+$688K
3
SGMO
SANGAMO THERAPEUTICS INC
SGMO
+$563K
4
SBAC icon
SBA Communications
SBAC
+$357K
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$330K

Sector Composition

Rank Sector Weight
1 Healthcare 22.41%
2 Technology 18.8%
3 Communication Services 14.71%
4 Financials 9.61%
5 Consumer Discretionary 8.46%

No holdings matched the selected filter criteria.

1 2 3 4 5

Similar funds

DGI
Discovery Group I Chicago, Illinois $262M AUM 29.24% 1-Year Est. Return
GIIO
Gen IV Investment Opportunities New York $269M AUM 21.06% 1-Year Est. Return
UBWV
United Bank (West Virginia) Parkersburg, West Virginia $252M AUM 13.13% 1-Year Est. Return
SC
ShearLink Capital New York $251M AUM 19.67% 1-Year Est. Return
EM
EnTrustPermal Management New York $240M AUM 25.21% 1-Year Est. Return
SIMC
Stillwater Investment Management (California) Palo Alto, California $234M AUM 21.36% 1-Year Est. Return
BSWMG
Barrington Strategic Wealth Management Group Chicago, Illinois $198M AUM 10.24% 1-Year Est. Return
PCMI
Princeton Capital Management Inc Princeton, New Jersey $198M AUM 28.98% 1-Year Est. Return

FIC Capital's Q3 2017 Portfolio in Review

As of Q3 2017, FIC Capital held 121 positions worth $262M, up 8% from $243M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

FIC Capital's Q3 2017 filing shows 5 new, 22 increased, 60 reduced and 2 closed positions. Its largest new stake was INPHI CORPORATION: 23,150 shares worth $919K. The largest sale was Alnylam Pharmaceuticals, an estimated $1.68M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 20% a quarter earlier, followed by Technology and Communication Services.

  • FIC Capital's largest Q3 2017 buy was INPHI CORPORATION: 23,150 shares worth $919K.
  • FIC Capital added most to Vanguard Short-Term Bond ETF in Q3 2017, an estimated $1.39M increase.
  • FIC Capital's biggest Q3 2017 reduction was Alnylam Pharmaceuticals, cutting an estimated $1.68M.
  • FIC Capital fully exited Rockwell Collins in Q3 2017, selling an estimated $688K.
  • FIC Capital's ten largest holdings make up 38% of its $262M portfolio in Q3 2017.
  • FIC Capital opened 5 new positions and closed 2 in Q3 2017.
  • FIC Capital's portfolio value rose 8% quarter-over-quarter to $262M.

Based on FIC Capital's 13F filing for Q3 2017, filed 14 Nov 2017.